Company Filing History:
Years Active: 2021
Title: The Innovative Mind of Lou Wainwright
Introduction
Lou Wainwright, an inventive mind residing in Lynnfield, MA, has made significant contributions to the field of medical technology. With a focus on enhancing cancer treatment, his work primarily revolves around innovations that improve patient care and treatment effectiveness.
Latest Patents
Wainwright holds a patent for the "Gantry charged particle nozzle system—rolling floor interface apparatus and method of use thereof." This groundbreaking invention features a segmented rolling floor apparatus designed for charged particle cancer therapy systems. The segmented rolling floor comprises a first spool and a second spool at opposite ends, allowing it to wind and unwind effectively. It circumferentially surrounds a nozzle system that penetrates through an aperture in the floor to deliver charged particles from an accelerator directly to a tumor. This design not only facilitates the treatment as the gantry rotates around the patient but also ensures that the floor remains safe and walkable during the process.
Career Highlights
Wainwright's career is marked by his innovative contributions to medical technology, particularly in the realm of cancer treatment methodologies. His patent reflects a deep understanding of both engineering and medical needs, showcasing his ability to blend technology with healthcare.
Collaborations
Throughout his career, Wainwright has collaborated with notable professionals such as Jillian Reno and Armin Huseinovic. These collaborations likely reflect a dynamic work environment focused on pushing the boundaries of what is possible in cancer therapy.
Conclusion
As an inventor, Lou Wainwright exemplifies the spirit of innovation in medical technology. His patented invention is a testament to his commitment to improving patient care and advancing treatment options for cancer. Through his work, he continues to inspire others in the field and contribute valuable solutions to complex medical challenges.